PHARMACOLOGICAL OPTIONS IN THE TREATMENT OF LIPID DISORDERS

被引：0

作者：

GROENEWOUD, YA ^{[1
]}

LEITER, LA ^{[1
]}

机构：

[1] UNIV TORONTO,DEPT MED,TORONTO M5B 1W8,ON,CANADA

来源：

HOSPITAL FORMULARY | 1994年 / 29卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Studies show that improving a patient's Lipid profile may help to prevent or alter the course of coronary artery disease. In addition to bile acid sequestrants, nicotinic acid, fibrates, HMG-CoA reductase inhibitors, and probucol, estrogens and omega-3 fatty acids also have shown benefits in lipid, modification. In choosing among these agents, the practitioner should consider their relative potency and costs, as well as the type of lipid disorder and, the patient's needs and wishes.

引用

页码：36 / &